The Translational Synthetic Biology lab of the Department of Medicine and Life Sciences (MELIS-UPF) has published an important advance in synthetic biology with skin bacteria. Specifically, they have managed to modify the bacterium Cutibacterium acnes so that it secretes and produces molecules to treat acne.
The technique they have developed could be used to treat various skin conditions by avoiding the use of drugs that destabilise the skin microbiome.
In this video, Nastassia Knödlseder, lead author of the study, explains their results and potential applications.
Knödlseder, N.J, et al., Delivery of a sebum modulator by an engineered skin microbe in mice. Nat. Biotechnol. 2024. Jan. doi.org/10.1038/s41587-023-02072-4